ClearPoint Neuro WKN: A2PZ3E ISIN: US18507C1036 Kürzel: CLPT Forum: Aktien Thema: Hauptdiskussion

Danke 👍

We're proud to announce installation of our system at Hôpital Fondation Rothschild Paris advancing our strategy to set up more trial centers in the EU, UK & Middle East to support both our biologics & device partnerships. See more: https://t.co/ooEDMBOPT6 @FondARothschild #CLPT https://t.co/3ENpIhIWYa

Watch

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution https://www.globenewswire.com/news-release/2021/07/21/2266822/25687/en/Blackrock-Neurotech-ClearPoint-Neuro-to-Address-Neurological-Disorders-With-Novel-Brain-Computer-Interface-Surgical-Solution.html

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland https://www.globenewswire.com/news-release/2021/06/16/2248533/0/en/ClearPoint-Neuro-Inc-Announces-Installation-of-ClearPoint-2-0-Software-at-Mazowiecki-Szpital-Br%C3%B3dnowski-in-Poland.html

Danke dir 👍

Nettes write up imo 😎 https://maxwellhouse99.substack.com/p/2-clearpoint-neuro-insane-in-the?r=cu51m&utm_campaign=post&utm_medium=web&utm_source=twitter

ClearPoint Neuro Set to Join Russell 3000® Index https://www.globenewswire.com/news-release/2021/06/14/2246614/0/en/ClearPoint-Neuro-Set-to-Join-Russell-3000-Index.html ...is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.   ....

💎👍🏻

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease https://www.globenewswire.com/news-release/2021/06/08/2243505/25687/en/ClearPoint-Neuro-Inc-Congratulates-BlueRock-Therapeutics-on-First-Patient-Dosed-with-DA01-in-Phase-1-Study-in-Patients-with-Advanced-Parkinson-s-Disease.html First Ever Stem Cell Clinical Trial Patient Treated Using Entire ClearPoint Platform

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software https://www.globenewswire.com/news-release/2021/05/18/2232002/0/en/ClearPoint-Neuro-Inc-Announces-First-in-Human-Cases-of-the-SmartFrame-Array-Neuro-Navigation-System-and-Software.html

https://www.fool.com/earnings/call-transcripts/2021/05/12/clearpoint-neuro-inc-clpt-q1-2021-earnings-call-tr/

👍

ClearPoint Neuro EPS beats by $0.01, beats on revenue https://seekingalpha.com/news/3694800-clearpoint-neuro-eps-beats-0_01-beats-on-revenue • ClearPoint Neuro (NASDAQ:CLPT): Q1 GAAP EPS of -$0.13 beats by $0.01. • Revenue of $4.03M (+29.2% Y/Y) beats by $0.76M.

ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’ https://www.globenewswire.com/news-release/2021/05/11/2227629/25687/en/ClearPoint-Neuro-Reports-Record-Revenue-in-First-Quarter-2021-Results-Announces-FDA-Clearance-of-the-SmartFrame-Array.html

ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room https://www.globenewswire.com/news-release/2021/05/10/2226744/0/en/ClearPoint-Neuro-Announces-Partnership-With-D-K-Engineering-for-Development-of-Robotic-System-for-the-MRI-Suite-and-Operating-Room.html